Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Daidzein Tablets

Approval Number

国药准字H21021233

Company沈阳君元药业有限公司

Registration Date

January 11, 2022

Previous Approval Numbers

国药准字H21021233

Drug Information

Generic Name

黄豆苷元片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

January 11, 2022

Company Information

Applicant Company

Company Name沈阳君元药业有限公司

Company Address

辽宁省沈阳市浑南区麦子屯603号沈阳浑南生物医药产业园9号楼

Manufacturing Company

Company Name沈阳君元药业有限公司

Company Address

沈阳市东陵区凌云街103巷6号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy